After several bouts with respiratory infection, Jessie Daw was diagnosed with smoldering multiple myeloma in 2016. She has considered clinical trials, but thus far, has stayed with the “watch-and-wait” approach. Jessie is a co-founder and leader of the Eastern South Dakota Multiple Myeloma Support Group. This will be her first time attending the ASH conference. 

Follow Jessie on Twitter: @Daw6Jessie
Support Group Website: Eastern South Dakota Multiple Myeloma Support Group

 

That’s an ASH Wrap!

That’s an ASH Wrap!

Attending the 63rd American Society of Hematology (ASH) meeting for the first time was an illuminating experience! I feel quite privileged to be a part of the International Myeloma Foundation (IMF) team and to have this educational opportunity. This was an amazing experience and I’m so grateful! Thank you, IMF and my fellow team members! In my Pre-ASH blog, I organized the SMM abstracts into five (5) categories. To wrap things up, it makes sense to provide highlights from those categories. In...

read more
Mental Health and Myeloma Research

Mental Health and Myeloma Research

As I mentioned in my previous blog, “What are You Going to Fill Your Glass with?” I reviewed a variety of sessions dealing with various aspects of mental health. Almost all of them were poster sessions, which I personally like because they have such a different feel from oral presentations (at least in my field; I imagine it’s the same at ASH).  In poster sessions, posters are placed in aisles, and you get to walk around a large room with the presenters standing nearby. You can stop and...

read more
What are You Going to Fill your Glass with?

What are You Going to Fill your Glass with?

As a Ph.D. with a focus in sport and exercise psychology (Kinesiology, Illinois, 1999), I naturally want to understand thought processes and emotions, and how they influence behavior. As a myeloma support group leader, I also participate in discussions with those on their myeloma pathway. And, as someone diagnosed with smoldering myeloma, I have evaluated (and constantly evaluate) my own pathway from a psychological perspective. This is natural for me, as this is life with a capital “L.” My...

read more
Under the Bright Lights of ASH

Under the Bright Lights of ASH

December 10, Friday  Friday was a light day, program-wise. Even so, I was immersed quickly into the bright lights of ASH. I learned a lot by attending an excellent symposium, Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma, moderated by Dr. Brian Durie (IMF & Cedars-Sinai), and including myeloma specialists Dr. Jesus San-Miguel (University of Navarra, Spain), Dr. Philippe Moreau...

read more
Pre-ASH Blog: Onward to ASH!

Pre-ASH Blog: Onward to ASH!

Wow! I’m continually amazed by all top-notch doctors and researchers who focus on finding new and better approaches to deal with myeloma – whether in the active multiple myeloma space or the smoldering multiple myeloma space. As I was thrust (unceremoniously, I should add) into the world of myeloma five years ago, I’ve learned about the astonishing advances in myeloma treatment in recent years.   This year, I’m thrilled to be able to play a part in sharing latest research findings. I...

read more